✦ LIBER ✦

The PROTECT study: final results of a large multicenter postmarketing study in patients with type 2 diabetes

✍ Scribed by John Buse; Kay Hart; Lori-ann Minasi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PROTECT interim results: a large multice

✍ Alain Baron; Christopher Neumann 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 613 KB

Postmarketing study of nateglinide in Ja

✍ Hiroto Taki; Toshio Maki; Takako Iso; Shintaro Tanabe; Taiichi Kajiura 📂 Article 📅 2005 🏛 Springer Healthcare Communications 🌐 English ⚖ 448 KB

Postmarketing surveillance study of piog

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Gliclazide modified release: results of

✍ P. Drouin; E. Standl; for the Diamicron MR Study Group 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Alemtuzumab in chronic lymphocytic leuke

✍ Fiegl, M.; Stauder, R.; Steurer, M.; Mian, M.; Hopfinger, G.; Brychtova, Y.; Skr 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 300 KB

Estimating cardiovascular risk in patien

✍ Marilia B Gomes; Daniel Giannella-Neto; Manuel Faria; Marcos Tambascia; Reine M 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 390 KB